| 产品名称： | C5/MJ |
|---|---|
| 商品货号： | TS212518 |
| Organism： | Homo sapiens, human |
| Tissue： | cord blood |
| Cell Type： | T lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 xa0Cells contain Retrovirus
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Leukemia |
| Age： | newborn |
| Gender： | male |
| Applications： | The cells produce Human T cell Leukemia virus (HTLV-I) and HTLV related antigens. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | This line was established by Popovic et al. in 1983 from neonatal cord blood by co-cultivation with an HTLV-I producing cell line, MJ (see ATCC CRL-8294). |
| Clinical Data： | male
neonatal |
| Comments： | The cells express a cell surface glycoprotein of 61000 daltons (45000 daltons when not glycosylated) that is characteristic of HTLV infection. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Iscoves Modified Dulbeccos Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
|
| Subculturing： | Cultures can be maintained by addition or replacement of fresh medium. Establish new cultures at about 2 to 4 x 105xa0cells/mL and maintain between 4 x 105xa0and 1 x 106xa0cells/mL.
Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:3 is recommended
Medium Renewal: Twice per week |
| Cryopreservation： | Complete growth medium, 95%; DMSO, 5%.xa0Cell culture tested DMSO is available as ATCC Catalog No. 4-X. |
| Culture Conditions： | Temperature: 37°C Atmosphere: Air, 95%; Carbon dioxide (CO2), 5% |
| STR Profile： | Amelogenin: X,Y CSF1PO: 9,11 D13S317: 12 D16S539: 8,11 D5S818: 13 D7S820: 11,12 THO1: 6,9 TPOX: 8 vWA: 16,17 |
| Name of Depositor： | President and Fellows of Harvard College |
| Deposited As： | Homo sapiens |
| U.S. Patent Number： | |
| Year of Origin： | 1983 |
| References： | Essex ME, Lee TH. Method and products for detection of human T cell leukemia virus. US Patent 4,743,678 dated May 10 1988 Popovic M, et al. Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science 219: 856-859, 1983. PubMed: 6600519 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | C5/MJ |
|---|---|
| 商品货号： | TS212518 |
| Organism： | Homo sapiens, human |
| Tissue： | cord blood |
| Cell Type： | T lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 xa0Cells contain Retrovirus
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Leukemia |
| Age： | newborn |
| Gender： | male |
| Applications： | The cells produce Human T cell Leukemia virus (HTLV-I) and HTLV related antigens. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | This line was established by Popovic et al. in 1983 from neonatal cord blood by co-cultivation with an HTLV-I producing cell line, MJ (see ATCC CRL-8294). |
| Clinical Data： | male
neonatal |
| Comments： | The cells express a cell surface glycoprotein of 61000 daltons (45000 daltons when not glycosylated) that is characteristic of HTLV infection. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Iscoves Modified Dulbeccos Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
|
| Subculturing： | Cultures can be maintained by addition or replacement of fresh medium. Establish new cultures at about 2 to 4 x 105xa0cells/mL and maintain between 4 x 105xa0and 1 x 106xa0cells/mL.
Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:3 is recommended
Medium Renewal: Twice per week |
| Cryopreservation： | Complete growth medium, 95%; DMSO, 5%.xa0Cell culture tested DMSO is available as ATCC Catalog No. 4-X. |
| Culture Conditions： | Temperature: 37°C Atmosphere: Air, 95%; Carbon dioxide (CO2), 5% |
| STR Profile： | Amelogenin: X,Y CSF1PO: 9,11 D13S317: 12 D16S539: 8,11 D5S818: 13 D7S820: 11,12 THO1: 6,9 TPOX: 8 vWA: 16,17 |
| Name of Depositor： | President and Fellows of Harvard College |
| Deposited As： | Homo sapiens |
| U.S. Patent Number： | |
| Year of Origin： | 1983 |
| References： | Essex ME, Lee TH. Method and products for detection of human T cell leukemia virus. US Patent 4,743,678 dated May 10 1988 Popovic M, et al. Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science 219: 856-859, 1983. PubMed: 6600519 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. |
